October 30, 2015
General
Following an intensive investigation into the practices of pharmaceutical giant Warner Chilcott U.S. Sales LLC, the company has agreed to settle criminal and civil allegations of healthcare fraud for $125 million as well as plead guilty to one felony count of healthcare fraud. In October 2015, the former president of […]
October 29, 2015
General
What is off-label marketing? When it comes to pharmaceutical marketing, it may seem like the options are virtually endless for a company seeking to boost sales and increase exposure of its product. However, despite the relentless television commercials and internet ads, there are a number of restrictions placed on the […]
October 28, 2015
General
With just one week before the start of a False Claims Act trial involving drug manufacturer Novartis Pharmaceuticals, the company decided to avoid the unpredictability of a jury in favor of a calculated $390 million settlement. The company is facing several False Claims Act lawsuits involving a number of different […]
October 27, 2015
General
In yet another case of defense contractor fraud, a company known as APL, Ltd. has agreed to pay $9.8 million to the federal government amid allegations of false billing. APL is a Scottsdale, Arizona-based subsidiary of Singapore’s Neptune Orient Lines Limited, a global shipping company engaged in the transcontinental transport […]
October 26, 2015
Canada News
Morganti Legal (Toronto) and Faguy & Co. (Montreal), announce that on Monday, October 26, 2015, they issued a class action claim in Quebec on behalf of all investors that purchased the securities of Valeant Pharmaceuticals International Inc. listed on the Toronto Stock Exchange and the Swiss Stock Exchange. (TSX and SIX: “VRX”). Investors […]
October 26, 2015
General
In some cases, a company facing possible liability under the False Claims Act may opt to self-report and self-disclose the potential violations, which typically results in a lesser fine and may help offset some of the statutory penalties awaiting violators of the Act. In today’s case, we review a recent […]
October 25, 2015
Canada News
Cy Moscow, partner of leading Detroit-based law firm Honigman Miller Schwartz & Cohn LLP and adjunct professor at University of Michigan School of Law, has once again invited Andrew Morganti to lecture to the third-year law students in his advanced securities regulations course on the topic of shareholders’ rights litigation […]
October 23, 2015
Canada News
TORONTO, Oct. 23, 2015 /CNW/ – Morganti Legal, a cross-border law firm focused on representing investors, has commenced an investigation into potential violations of securities laws by Valeant Pharmaceuticals International Inc. (TSX and NYSE: “VRX”) in respect of allegations that Valeant may have released materially misleading business information to the investing public […]
October 23, 2015
General
Under federal regulations, government healthcare programs like Medicare and Medicaid are only available to cover end-of-life services once a patient has reached a terminal point in their illness or injury. Unlike curative care, palliative care is only designed to make a patient more comfortable. Program regulations state that curative methods […]
October 22, 2015
General
Ideally, False Claims Act lawsuits are resolved via a negotiated settlement between the whistleblower, the defendant, and the government. However, if a settlement agreement cannot be reached, the parties must press on toward a trial – an option that sets up both sides for a greater amount of unpredictability and […]
October 21, 2015
General
A Kentucky-based company known as Nurses’ Registry and Home Health Corp. has agreed to pay $16 million to settle False Claims Act allegations that it defrauded the Medicare program. The case was originally filed by two whistleblowers – former employees of the company – who suspected it was exaggerating the […]
October 20, 2015
General
In one of the larger healthcare fraud settlements of 2015, Millennium Health, LLC has agreed to pay $256 million to settle allegations it engaged in fraudulent and illegal activity with regard to urine drug screens and orders for urinalysis. The case got its start thanks to a lawsuit filed by […]